dividends
RP
NASDAQ · RPRX
Royalty Pharma plc
Healthcare · Biotechnology
$58.47
Up+$0.30 (+0.51%)
Updated Sep 16, 2026, 3:12 PM
SID Score
7.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 16.85B
- P/E ratio
- 16.44
- Dividend yield
- 1.51%
- 52-week range
- $34.63 – $64.38
- Volume
- 2.75M
- Avg. volume
- 4.22M
Price performance
RPRX price history
1M range · 20 trading sessions · Daily adjusted prices
RPRX closed at $58.47 after 20 trading sessions, down 2.04% for the selected period.
- Last close
- $58.47
- Period change
- -2.04%
- Period low
- $58.47
- Period high
- $63.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $59.00 | $59.20 | $57.91 | $58.47 | 2.75M |
| Sep 14, 2026 | $58.66 | $59.55 | $57.75 | $59.05 | 2.97M |
| Sep 11, 2026 | $58.95 | $59.54 | $58.35 | $58.61 | 2.6M |
| Sep 10, 2026 | $60.445 | $60.71 | $58.64 | $58.75 | 3.32M |
| Sep 9, 2026 | $60.60 | $60.80 | $59.31 | $60.59 | 4.34M |
| Sep 8, 2026 | $59.21 | $60.86 | $58.63 | $60.59 | 8.63M |
| Sep 4, 2026 | $63.55 | $64.38 | $63.43 | $63.96 | 3.4M |
| Sep 3, 2026 | $63.565 | $63.94 | $62.50 | $63.88 | 2.76M |
| Sep 2, 2026 | $62.66 | $63.285 | $62.03 | $63.11 | 3.14M |
| Sep 1, 2026 | $61.815 | $62.58 | $61.61 | $62.32 | 2.63M |
| Aug 31, 2026 | $60.805 | $61.68 | $60.39 | $61.41 | 3.9M |
| Aug 28, 2026 | $61.92 | $62.01 | $60.6553 | $60.85 | 1.7M |
| Aug 27, 2026 | $61.42 | $62.35 | $61.01 | $61.92 | 2.09M |
| Aug 26, 2026 | $62.04 | $62.28 | $61.49 | $61.80 | 1.48M |
| Aug 25, 2026 | $61.33 | $62.455 | $60.87 | $62.07 | 1.71M |
| Aug 24, 2026 | $61.19 | $61.54 | $60.8043 | $61.33 | 2.36M |
| Aug 21, 2026 | $60.53 | $61.60 | $60.37 | $61.31 | 2.33M |
| Aug 20, 2026 | $61.33 | $62.13 | $60.37 | $60.58 | 3.14M |
| Aug 19, 2026 | $60.12 | $61.80 | $59.75 | $61.73 | 3.26M |
| Aug 18, 2026 | $59.74 | $60.42 | $59.655 | $59.69 | 2.08M |
Latest RPRX news
The latest Smart Investors Daily articles mentioning RPRX.
Stock researchResearch & News · SEC Filings
Loading stock research…

